|
[1]CHUANG N,GROSS RG,ODIN JA.Update on the epidemiology of primary biliary cirrhosis[J].Expert Rev Gastroenterol Hepatol,2011,5(5):583-590.
|
|
[2]SAKUGAWA H,NAKASONE H,NAKAYOSHI T,et al.Epidemiology of primary biliary cirrhosis among women with elevated gamma-glutamyl transpeptidase levels in Okinawa,Japan[J].Hepatol Res,2003,26(4):330-336.
|
|
[3]JIANG XH,ZHONG RQ,FAN XY,et al.Characterization of M2 antibodies in asymptomatic Chinese population[J].World J Gastroenterol,2003,9(9):2128-2131.
|
|
[4]LIU H,LIU Y,WANG L,et al.Prevalence of primary biliary cirrhosis in adults referring hospital for annual health checkup in Southern China[J].BMC Gastroenterol,2010,10:100.
|
|
[5]HE YQ,LIU Q,YE ZX,et al.11024 cases of anti-mitochondrial antibody type M2 screening results[J].Mod Med J China,2015,11(17):1-3.(in Chinese)何宇晴,刘强,叶震璇,等.M2型线粒体抗体筛查11024例结果分析[J].中国现代医药杂志,2015,11(17):1-3.
|
|
[6]HIRSCHFIELD GM,LIU X,XU C,et al.Primary biliary cirrhosis associated with HLA,IL12A,and IL12RB2 variants[J].N Engl J Med,2009,360(24):2544-2555.
|
|
[7]CORDELL HJ,HAN Y,MELLS GF,et al.International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways[J].Nat Commun,2015,6:8019.
|
|
[8]NAKAMURA M,NISHIDA N,KAWASHIMA M,et al.Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population[J].Am J Hum Genet,2012,91(4):721-728.
|
|
[9]DONG M,LI J,TANG R,et al.Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population[J].Clin Rev Allergy Immunol,2015,48(2-3):316-321.
|
|
[10]BOGDANOS DP,KOMOROWSKI L.Disease-specific autoantibodies in primary biliary cirrhosis[J].Clin Chim Acta,2011,412(7-8):502-512.
|
|
[11]HU SL,ZHAO FR,HU Q,et al.Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis[J].PLo S One,2014,9(7):e101916.
|
|
[12]LIU H,NORMAN GL,SHUMS Z,et al.PBC Screen:an Ig G/Ig A dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis[J].J Autoimmun,2010,35(4):436-442.
|
|
[13]WENDUM D,BOLLE PY,BEDOSSA P,et al.Primary biliary cirrhosis:proposal for a new simple histological scoring system[J].Liver Int,2015,35(2):652-659.
|
|
[14]Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis(cholangitis)[J].J Clin Hepatol,2015,31(12):1980-1988.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识[J].临床肝胆病杂志,2015,31(12):1980-1988.
|
|
[15]LAMMERS WJ,HIRSCHFIELD GM,CORPECHOT C,et al.Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy[J].Gastroenterology,2015,149(7):1804-1812.
|
|
[16]CARBONE M,SHARP SJ,FLACK S,et al.The UK-PBC risk scores:derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis[J].Hepatology,2016,63(3):930-950.
|
|
[17]RAUTIAINEN H,KRKKINEN P,KARVONEN AL,et al.Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis:a three-year randomized trial[J].Hepatology,2005,41(4):747-752.
|
|
[18]HEMPFLING W,GRUNHAGE F,DILGER K,et al.Pharmacokinetics and pharmacodynamic action of budesonide in early-and lat-stage primary biliary cirrhosis[J].Hepatology,2003,38(1):196-202.
|
|
[19]ZHANG Y,LI S,HE L,et al.Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy:a meta-analysis[J].Drug Des Devel Ther,2015,9:2757-2766.
|
|
[20]YIN Q,LI J,XIA Y,et al.Systematic review and meta-analysis:bezafibrate in patients with primary biliary cirrhsis[J].Drug Des Devel Ther,2015,9:5407-5419.
|
|
[21]HIRSCHFIELD GM,MASON A,LUKETIC V,et al.Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid[J].Gastroenterology,2015,148(4):751-761.
|
|
[22]CAREY EJ,ALI AH,LINDOR KD.Primary biliary cirrhosis[J].Lancet,2015,386(10003):1565-1575.
|
|
[23]CARBONE M,NEUBERGER J.Liver transplantation in PBC and PSC:indications and disease recurrence[J].Clin Res Hepatol Gastroenterol,2011,35(6-7):446-454.
|
|
[24]BOSCH A,DUMORTIER J,MAUCORT-BOULCH D,et al.Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis[J].J Hepatol,2015,63(6):1449-1458.
|
DownLoad: